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Abstract
Introduction: Viral hepatitis is a global public health problem affecting millions 
of people every year, causing disability and death. Hepatitis B (HBV) and hepatitis C 
(HCV) viruses spread horizontally, mainly through sexual contact and contaminated 
needles, and vertically. Both cause considerable morbidity and mortality worldwide. 
Maternal infection is a risk factor for vertical transmission. Objective: To determine 
the seroprevalence of HBsAg and anti-HCV antibody among non-pregnant, appar-
ently healthy mothers and to identify potential risk factors associated with HBV or 
HCV infection. Methods: A community based cross sectional study was conducted on 
454 apparently healthy women, in Addis Ababa, Ethiopia from May 2016 to June 2017. 
A systematic random sampling method was used to recruit participants. Result: A total 
of 454 mothers were enrolled. Seroprevalence of HBsAg and HCV was found to be 
3.7% and 2.0%, respectively. HBc antibody was detected in 36.3% of the mothers. None 
of the participants was co-infected with both viruses. Previous history of liver disease, 
history of jaundice, HIV infection, and family history of liver disease were signifi-
cantly associated with HBV infection. Marital status, caring for hepatitis patients, 
and a history of liver disease were factors significantly associated with HCV infection. 
Conclusion: Apparently, healthy mothers in Addis Ababa had intermediate level of 
endemicity for hepatitis B and C infections Routine screening and vaccination of high-
risk reproductive mothers against HBV is advisable. Emphasis should be given to health 
education and promotion of infection control practices. Population based studies are 
strongly recommended to help monitor disease transmission patterns and to design 
evidence-based interventions against the spread of hepatitis infections in Ethiopia.
Keywords: Sero-prevalence, risk factors, hepatitis B and C virus,  
apparently healthy mothers
1. Introduction
Viral hepatitis is one of the major causes of chronic liver disease and liver failure. 
In many countries, viral hepatitis is the leading cause of liver transplants. Such 
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end-stage treatments are expensive, easily reaching up to hundreds of thousands of 
dollars per person [1]. In addition, viral hepatitis places a heavy burden on the econ-
omy of nations due to loss of productivity. Although the burden of viral hepatitis is 
very high, it has not received the attention it deserved from the global community 
[1, 2]. Various reasons account for this negligence, including the relatively recent 
discovery of the causative viruses, the mostly silent or benign nature of the disease 
in its early stages, and the insidious way in which it causes chronic liver disease [1].
Among viral hepatitis, hepatitis B and C infections are more often seen in 
blood, tissue, or organ recipients and people working or receiving treatment in 
health care facilities [2]. The WHO has estimated that there are more than 2 billion 
people infected with hepatitis B virus (HBV) and about 378 million HBV carriers 
worldwide, leading to approximately 620, 000 HBV related deaths every year [2, 3] 
. Further, it has been reported that 4.5 million new HBV infections occur worldwide 
each year, of which a quarter progresses to liver disease [2, 3].
HBV infection is endemic in Asia and sub-Saharan Africa thought to be the main 
etiological factor in over 75% of the chronic liver disease burden [3]. In sub-Saharan 
Africa, the prevalence of HBV surface antigen (HBsAg), which indicates active 
infection, is 3–20% and prevalence of markers for past exposure range from 60 to 
99.Since Ethiopia is located in Sub-Saharan Africa, it is considered an area of high 
endemicity for HBV infection.
Meanwhile, approximately 170 million individuals are infected with hepatitis C 
virus worldwide, leading to approximately 250 000 to 350 000 deaths per year [4].
Viral hepatitis is a key public health problem that poses an enormous risk for 
disease transmission in the general population, especially in children and moth-
ers [2]. Reliable epidemiological data are essential for planning health programs 
and identifying risk groups, For example, the selection of appropriate treatment 
depends on the genotype of the virus, the presence or absence of cirrhosis, and on 
the degree of liver fibrosis [2]. Therefore, it is important to know the number of 
people infected with and dying from hepatitis related liver disease, the prevalence 
of hepatitis related morbidity, and the distribution of genotypes and fibrosis stages 
[3]. Unfortunately, estimates of these key epidemiological parameters are limited by 
the lack of data from in developing countries like Ethiopia.
In Ethiopia, only few community-based seroepidemiology studies have previ-
ously been done on the prevalence of HBV and HCV. These studies, which were 
investigating the prevalence of these viruses among pregnant mothers, blood 
donors, HIV infected individuals, health care workers, and medical waste handlers, 
have indicated that hepatitis infections are endemic in Ethiopia, with varying levels 
of endemicity from region to region [5]. However, community based hepatitis 
studies focusing on the prevalence of hepatitis B or/and C infection in mothers 
have not been conducted. Thus, the current study aims to measure the prevalence 
of hepatitis B and C infection and contributing factors among apparently healthy 
mothers. This study is important to define the prevalence of these viral infections 
and associated risks among apparently healthy mothers, in order to adopt effective 
preventive strategies, guidelines, and educational programmers. Overall, screening 
asymptomatic people is important for early diagnosis and intervention.
2. Methods and materials
2.1 Study area
This study was conducted in Addis Ababa city, which has a population of 
about 3.6 million and an average household size of 5.8 persons per household [6]. 
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According to the 2007 national census, 98.6% of the housing units in Addis Ababa 
have access to safe drinking water. In addition, 14.9% have flush toilets, 70.7% have 
pit toilet, and 14.3% have no toilet facilities [7]. Values for other reported common 
indicators of the standard of living for Addis Ababa showed that as of 2012 0.1% of 
the inhabitants fall into the lowest wealth quintile [6]. Adult literacy for men and 
woman is 93.6% and 79.9% respectively the highest in the nation for both sexes. 
Further, the civic (urban) infant mortality rate is 45 infant deaths per 1,000 live 
births, which is less than the nationwide average of 77; at least half of these deaths 
occurred in the infants’ first month of life. HIV prevalence in Addis Ababa mothers 
was (5.2%) [7].
2.2 Study design, sample size and sampling procedures
A community based cross-sectional study was conducted from June 2016 to May 
2017. Administratively, Addis Ababa is divided into 10 Sub-cities and 116 Woredas. 
According to 2012 CSA, there are about around 700,000 households. Three sub-
cities (Gulele, Kirkos, and Lideta) and seven Woredas within these sub-cities were 
selected randomly. Health extension workers from each Woredas using systematic 
random sampling technique selected 50–70 households. The proportional allocation 
value, which was used for selection, was calculated by dividing the total number of 
households in the study area to the total number of selected households. In the end, 
454 non-pregnant apparently healthy mothers were included in this study.
2.3 Data collection and laboratory investigations
Five milliliter of venous blood was collected and transported to the laboratory, 
where it was allowed to clot. Then, serum was separated by centrifugation at room 
temperature at 3000 rpm for four minutes, and then it was stored at −20°C until 
further use.
The principal investigator used a structured interview to collect data on socio-
demographic variables and associated risk factors from the study participants. 
Principal investigator collected the data.
Sandwich Elisa was used to measure serum level HBsAg, Anti-HBc, and anti-HCV 
in all samples Bio-Rad ELISA kits were used for this study [8].
2.4 Data processing and analysis
Data entry and analysis was done using SPSS version 20.0. Chi-square test was 
used to determine the association between serological results and different hepatitis 
infection associated factors. In addition, it was used to compare categorical data, to 
evaluate the difference in prevalence between groups in the bivariate logistic analy-
sis, and to determine statistical significance. To determine the association between 
the data obtained from the questionnaire and the laboratory results, odds ratios 
(ORs) and their corresponding 95% confidence intervals (CIs) were calculated 
using logistic regression analysis. A p-value <0.05 was considered as statistically 
significant.
2.5 Quality assurance
Standard operating procedures were followed during blood sample collection, 
processing, and analysis of data. All ELISA experiments were conducted according 
to the manufacturer’s instruction. The performance of Monolisa™ HBsAg ULTRA 
was determined using test samples. A sensitivity of 100% and a specificity of 
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99.94% were recorded. The Monolisa™ Anti-HBc PLUS test resulted in 99.53% sen-
sitivity and 99.5% specificity. The Monolisa™ HCV Ag-Ab ULTRA assay had 100% 
sensitivity and 99.83% specificity. According to the manufacturer’s instruction, 
positive samples were tested in duplicates before final interpretation. In addition, 
positive and negative controls were run as the test runs.
2.6 Ethical considerations
The study received ethical approval from Ethical Review Committee and 
Institutional Review Board (IRB) of Addis Ababa University, College of Health 
Sciences, Department of Microbiology, Immunology and Parasitology and the 
Armauer Hansen Research Institute (AHRI). Support letter was obtained from 
Addis Ababa Health Bureau.
3. Results
3.1 Socio-demographic characteristics
A total of 454 mothers were involved in this study and the mean age of the study 
subjects was 32.75 ± 5.79 (SD) years, (range: 20 to 57 years). Majority of the moth-
ers belonged to the 30–34 age group (33.5%), followed by 25–29 (25.1%) and 35–39 
(25.1%) age group. Further, most (81.7%) of the study participants were married 
(Table 1).
3.2 Prevalence of HBV and HCV infection
Overall, 42.3% (95% CI: 39.5–46.1%) of apparently healthy mothers were 
positive for HBsAg, HBcAb or HCV antibody. The sero-prevalence for HBsAg 
was 17/454 (3.7%), while it was 165/454 (36.3%) for HBcAb and 9/454 (2.0%) for 
anti-HCV. 17/454 (3.7%) of the study participants were positive for both HBsAg and 
HBcAb. The prevalence of HBV and HCV infection segregated by age can be found 
in Table 2.
3.3 Risk factors associated with HBV and HCV infections
A positive association was observed between HBsAg seropositivity and par-
ticipants’ number of households (p = 0.017), history of liver diseases p = 0.01), 
history of jaundice (p = 0.00), and family history of liver disease (p = 0.04) at 
95% confidence interval. Among participants with history of liver disease (n = 31), 
history of jaundice (n = 9), and family history of hepatitis (n = 38), the prevalence 
of HBsAg was 13.9%, 30.8% and 10.5% respectively. On the other hand, age, level 
of education, marital status, occupation, alcohol consumption habits, caring 
for hepatitis patients, history of operation or cesarean section, history of female 
genital mutilation, history of sharp injury, history of blood transfusion, history 
of ear-piercing, dental procedure, having multiple sexual partner, and history 
of abortion, did not have significant association with having hepatitis B virus 
infection.
In addition, binary and multivariate logistic regressions were used to determine 
the association between the HBV associated risk factors with HBV infection. Few 
predictor variables showed statistically significant association with HBV infections. 
Mothers with a history of hepatitis were 5.5 times more likely to be HBV posi-
tive than mothers who had no such history (AOR = 5.5; CI (1.8–16.5); p = 0.003). 
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Mothers who had a history of jaundice (AOR = 17.8 CI; (4.0–75.5); p = 0.03) were 
17.8 times more likely to be HBV positive than their counterparts. Statistically 
significant association was observed between having contact with HBV infected 
household members and HBV infection (P = 0.05). Mothers who had previous 
history of household contact were 3.2 times more likely to have infection with 
HBV than those without previous history of household contact (AOR = 3.2; CI 
(1.0–10.4); P = 0.05) (Table 3).
Participants’ age group (p = 0.012), marital status (p = 0.05), caring for hepa-
titis patient (p = 0.01), blood transfusion history (p = 0.03), history of jaundice 
(p = 0.00), and family history of liver disease (p = 0.012) were significantly associ-
ated with HCV infection (Table 4). However, previous history of dental procedure, 
body tattooing, having multiple sexual partner, body piercing with sharp objects, 
and history of surgical procedure showed no significant association with having 
hepatitis C virus infection. In addition, HCV associated factors and their associa-
tion with HCV infection was determined using binary and multivariate logistic 
regression. History of jaundice (AOR = 19.2; CI (3.5–104.9); p = 0.02) and alcohol 
consumption habit (AOR = 6.9; CI (1.3–37.0); p = 0.02) _were significantly associ-
ated with HCV positivity at 95% confidence interval. In the multivariate analysis, 
Socio-demographic characteristics Numbers Percentage (%)
















Occupation Housewife 249 54.9
Employed 57 12.5
Daily laborer 55 12.1
Private 93 20.8





Socio-demographic characteristics of study participants.
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after adjustment for all other confounding variables, age group, marital status, 
history of blood transfusion and family history of liver disease has no impact on the 
acquisition of HCV infection as shown in Table 4.
4. Discussion
HBV and HCV infections are significant health problems around the globe. 
Both infections are associated with a broad range of clinical presentations ranging 
from clinically asymptomatic, acute hepatitis to chronic hepatitis and liver cirrhosis 
[9]. Population based serological studies conducted on viral hepatitis have demon-
strated the diversity of epidemiological patterns with regard to the risk of acquiring 
infection related to personal attributes, place and risk distribution [10]. Screening 
asymptomatic people is important for early diagnosis and intervention, which may 










Age group 20–24 21 0(0.0) 6(28.6) 0(0.0)
25–29 114 8(7.0) 34(29.9) 1(0.9)
30–34 152 7(4.6) 55(36.2) 4(2.6)
35–39 114 2(1.8) 40(35.1) 3(2.6)
40–44 34 0(0.0) 19(55.9) 0(0.0)
45–49 14 0(0.0) 8(57.1) 0(0.0)
50–54 3 0(0.0) 2(66.7) 1(33.3)
55–59 2 0(0.0) 1(50.0) 0(0.0)
Education Illiterate 52 0(0.0) 11(21.2) 1(2.0)
1–8 260 12(4.6) 97(37.3) 4(1.5)
9–12 106 3(2.8) 43(41.0) 3(2.8)
≥College 36 2(5.6) 14(38.9) 1(2.8)
Marital status Married 371 16(4.3) 137(37.2) 4(1.1)
Unmarried 9 1(11.1) 2(22.2) 0(0.0)
Divorced 67 0(0.0) 24(35.8) 4(6.0)
widowed 7 0(0.0) 1(28.6) 1(14.3)
Occupation Housewife 249 11(4,5 92(36.9) 4(1.6)
Employed 57 0(0.0) 23(40.4) 1(1.8)
Daily laborer 55 4(7.3) 16(29.1) 2(3.6)
Private 93 2(2.2) 34(36.6) 2(2.2)
Family size 1–4 194 3(1.5) 66(34.0) 2(1.0)
5–6 210 9(4.3) 77(36.7) 7(3.3)
≥7 50 5(10.0) 22(44.0) 0(0.0)
Total 454 17(3.7) 165(36.3) 9(2.0)
Table 2. 
The prevalence of HBsAg, HBcAb and anti-HCV antibodies segregated by socio-demographic characteristics.
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The results from this study revealed 3.7% sero-prevalence of HBsAg, which lies 
within the established standard intermediate endemicity of hepatitis B prevalence 
[11]. Even though this finding in agreement with the WHO intermediate level of 




















































































































































Association between different risk factors and HBV infection.
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endemicity, it may not represent the whole community. Because, this study mainly 
focuses on apparently healthy mothers in Addis Ababa, who represent only female 
populations; and it needs more inclusive sample from both sexes in order to argue 
the WHO established endemicity classifications. This result compares well with the 
results of a study conducted in Jimma on 493 pregnant women, where the serop-
revalence was3.7% [12], and a study done in Addis Ababa on delivering women, 
which had sero-prevalence of 3.0% [13], and studies done in Woldia and south 
Gondar on diabetes and non-diabetic patients, where the seroprevalence for both 
was 3.7% [14]. The reported HBsAg prevalence of this study was higher than what 
was reported in studies conducted in Dessie on healthy female blood donors (1.5%) 
[15], in Addis Ababa on Public Health Centers cleaners (3.57%) [5], and in Jimma 
on blood donors 2.1% [16]. In contrast, it was lower than what was reported in stud-
ies conducted documented in Dessie on pregnant women (4.9%) [17], in Gondar, 
Bahir Dar, Dessie and Mekelle on blood donors (6.2%) [18], Shashemene (5.7%) 
[19], Ghana (10.6%) [20], and in Addis Ababa on the community (6.2%) [21]. The 
observed discrepancies in HBV distribution across different geographical loca-
tions might be attributed by variation in socio-demographic characteristics of the 
study population, such as socio-cultural environment, traditional practices, sexual 
practices, medical exposure, and the difference in hepatitis and other underlined 
disease epidemiology. Moreover, the variation could also be due to circulating 
genotypes, which is responsible for disease severity as well as treatment responses, 
methodological difference (test method, study design etc.), the level of awareness, 



























































































Total % 9(2.0) 445(98.0) 454
Table 4. 
Association between risk factors and HCV infection.
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The overall sero-prevalence of HCV (2.0%) in this study is similar to a study 
conducted in Gabon (2.1%) [22], a study conducted in Sudan (1.9%) [23], sero-
prevalence of the general population of Ethiopia (2.0%) [24], a study conducted in 
Poland (1.9%) [25] and a study conducted in northern Ethiopia volunteer testing 
and counseling center (2.0%) [26]. This finding was also comparable with other 
reports found in health center cleaners in Addis Ababa (1.59%) [5] and in blood 
banks at Gondar, Bahirdar, Dessie and Mekele (1.7%) [15].
In contrast, this finding was higher in a report from Dessie blood bank 
0.39% [15], Jimma adult blood donors 0.2% [17], Debretabor hospital among 
HIV patients 1.3% [25], Arba Minch blood bank, in southern Ethiopia 0.0% 
[24], in Dessie among pregnant mothers was 0.8% [27], 0.19% in Indian women 
[28], and in Nigerian pregnant women 1.39% [29]. Moreover, our finding was 
lower than what was reported in studies from Gondar (5%) [30], Hawassa 
(6%), Kigali (5.2%), Rwanda [31], and Ghana (7.7%) [32]. These differences 
may be attributed to difference in sensitivity and specificity of methods used, 
e.g. ELISA vs. Rapid test. Another reason for these differences could be using 
different study designs. Usually, facility based study designs have overestima-
tion because their population is composed of people that have already observed 
some of the symptoms of the infection. Sampling technique: those convenient 
sampling techniques usually are subjected to bias etc.), population variation, 
types of risk exposure and sample size that have a great effect on the result 
different studies.
In this study, most of socio-demographic variables were not associated with 
HCV infection. However, caring for hepatitis patients and history of jaundice were 
significantly associated with the occurrence of HCV infection. These findings were 
supported by a study conducted in Ethiopian public hospitals [30]. In the pres-
ent study, no statistical significant differences were observed for HBV and HCV 
infections in terms of age, sex, occupation and educational status. This study was 
supported by a study reported in Amhara regional state general populations [33] 
and a study done in Felege Hiwot Referral Hospital, northwest Ethiopia [34].
The highest prevalence of HBsAg was detected among apparently healthy 
mothers, who were 25–29 or 30–34 years old. This was in agreement with studies 
conducted in Shashemene General Hospital, southern Ethiopia; Shenyang, China; 
Debretabor hospital, South Gondar, Northwest Ethiopia; Addis Ababa, Ethiopia 
[9, 30, 35, 36], and Nigeria [29]. The observed high prevalence of HBV positivity 
among younger age group could be due to h the high probability of exposure to high 
risk health behaviors.
The present study investigated the association of HBV infection prevalence and 
level of education. Higher prevalence was observed among those with primary 
level of education. This finding was in agreement with previous study conducted in 
Ethiopia among pregnant women [36]. History of liver disease, history of jaundice, 
and family history of liver disease were significantly associated with HBV infection 
and were important predictors of HBV infection. These findings were supported by 
a study conducted in Bahirdar [37], in Debretabor hospital [27], Gondar hospital, 
[29], and in Karachi, Pakistan [38].
5. Conclusion
The present study showed 3.7% and 2.0% for HBV and HCV infection preva-
lence, respectively. This result was an intermediate prevalence of HBV and HCV 
infection among apparently healthy mothers. This was in line with World Health 
Organization’s regional HBV and HCV infection burdens [4, 9].
Hepatitis B
10
In our study setting, there was intermediate level of HBV and HCV prevalence 
apparently healthy mothers. Therefore, there is a need for timely intervention 
strategies to alleviate the burden of HBV and HCV infection in this community. 
This prevalence rate also calls for additional efforts regarding active screening and 
vaccination for young adults and public health education campaigns in the media to 
promote better awareness of viral hepatitis risk factors.
In this study, mothers within the ages of 24–29 and 30–34 had the two highest 
prevalence of HBV, 7.0% and 4.6% respectively. It may be at high risk and serves as a 
reservoir which requires routine screening and vaccine schedules (for HBV) may be 
important for those high risk groups.
This shows higher level of carrier status in mothers at reproductive age. This 
might increase risk of mother-to-infant transmission in the study areas.
Among the assessed variables and clinical presentations, previous history of 
liver disease, history of jaundice, and family history of liver disease were signifi-
cantly associated with HBV infections. On the other hand, marital status, con-
sumption of alcohol, and history of jaundice were significantly associated with the 
occurrence of HCV infection.
Scaling up of screening of pregnant and non-pregnant mothers for HBV and 
HCV infections and provision of health education about the risk factors, the mode 
of transmissions, and prevention are recommended. Population based studies with 
additional serological markers and molecular techniques are required to design a 
working strategy for evidence-based intervention. Therefore, screening apparently 
healthy mothers is an important tool in early diagnosis and intervention.
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